Jump to content

French research suggests benefit from chemo combination

PCUK Nurse Jeni

Recommended Posts

PCUK Nurse Jeni

A French research study published in the New England Journal of Medicine has shown a survival benefit from a combination chemotherapy regimen consisting of oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) for patients with metastatic pancreatic cancer. Although this combination does cause more side effects.

For more information see http://www.latimes.com/health/boostershots/la-heb-pancreatic-cancer-drug-cocktail-05112011,0,2372897.story

or http://www.nejm.org/doi/full/10.1056/NEJMoa1011923

Link to comment
Share on other sites

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.